KCI BioTech (Suzhou) Inc.
Ms. Li, the R&D leader of Chunhai Biotechnology, presented a banner to KCI BioTech
Colleagues from the Department of Biopharmaceuticals at KCI pose for a photo with Jinqi
About KCI BioTech (Suzhou) Inc.
KCI BioTech (Suzhou) Inc. and its wholly-owned subsidiary Jiangsu KMQ BioTech Inc. are committed to providing comprehensive preclinical new drug research and development services to global pharmaceutical companies and research institutions, and establishing a professional and efficient drug research and development evaluation system.KCI KMQ has two internationally advanced experimental animal facilities in Suzhou and Nantong, both of which have obtained international AAALAC certification, with a total area of over 18000 square meters; We have established a full range of experimental animal platforms including mice, hamsters, guinea pigs, rabbits, cats, dogs, pigs, ferrets, and non-human primates, over 400 animal models of tumors and non tumor diseases, ABSL-2/BSL-2 anti infective drug and vaccine evaluation experimental platforms, pathology, early toxicology cell and molecular biology, pharmacokinetics, medical imaging, and other research service platforms.